BHC Bausch Health Companies Inc

  1. Stocks
  2. Healthcare
  3. NYSE: BHC

Price (delayed)

$8.51

Market cap

$3.08B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.13

Enterprise value

$23.78B

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of ...

Highlights
The net income has soared by 60% YoY and by 57% from the previous quarter
BHC's EPS has surged by 60% year-on-year and by 57% since the previous quarter
The debt has declined by 2.4% year-on-year but it has increased by 2.3% since the previous quarter
The company's equity has shrunk by 104% QoQ and by 10% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.bauschhealth.com
Peers: OCUP

Key stats

What are the main financial stats of BHC
Market
Shares outstanding
361.48M
Market cap
$3.08B
Enterprise value
$23.78B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.37
EV/EBIT
26.6
EV/EBITDA
9.93
EV/Sales
2.86
Earnings
Revenue
$8.33B
EBIT
$894M
EBITDA
$2.4B
Free cash flow
$648M
Per share
EPS
-$1.13
Free cash flow per share
$1.8
Book value per share
-$0.6
Revenue per share
$23.07
TBVPS
$27.8
Balance sheet
Total assets
$29.09B
Total liabilities
$29.23B
Debt
$23.17B
Equity
-$216M
Working capital
$1.06B
Liquidity
Debt to equity
-107.26
Current ratio
1.22
Quick ratio
0.84
Net debt/EBITDA
8.65
Margins
EBITDA margin
28.8%
Gross margin
71.5%
Net margin
-4.9%
Operating margin
11.5%
Efficiency
Return on assets
-1.4%
Return on equity
N/A
Return on invested capital
3.5%
Return on capital employed
3.7%
Return on sales
10.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BHC stock price

How has the Bausch Health Companies stock price performed over time
Intraday
-3.62%
1 week
20.54%
1 month
-13.78%
1 year
-70.86%
YTD
-69.18%
QTD
-62.76%

Financial performance

How have Bausch Health Companies's revenue and profit performed over time
Revenue
$8.33B
Gross profit
$5.95B
Operating income
$956M
Net income
-$407M
Gross margin
71.5%
Net margin
-4.9%
The operating margin has soared by 117% from the previous quarter
The company's operating income has surged by 112% QoQ
The net margin has surged by 61% year-on-year and by 56% since the previous quarter
The net income has soared by 60% YoY and by 57% from the previous quarter

Growth

What is Bausch Health Companies's growth rate over time

Valuation

What is Bausch Health Companies stock price valuation
P/E
N/A
P/B
N/A
P/S
0.37
EV/EBIT
26.6
EV/EBITDA
9.93
EV/Sales
2.86
BHC's EPS has surged by 60% year-on-year and by 57% since the previous quarter
The company's equity has shrunk by 104% QoQ and by 10% YoY
The price to sales (P/S) is 65% lower than the last 4 quarters average of 1.1 and 58% lower than the 5-year quarterly average of 0.9
The revenue has increased by 3.5% year-on-year

Efficiency

How efficient is Bausch Health Companies business performance
BHC's return on sales has surged by 133% since the previous quarter
BHC's return on invested capital has surged by 133% since the previous quarter
The ROA has soared by 58% YoY and by 56% from the previous quarter

Dividends

What is BHC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BHC.

Financial health

How did Bausch Health Companies financials performed over time
Bausch Health Companies's quick ratio has increased by 22% YoY and by 12% from the previous quarter
The current ratio has grown by 13% from the previous quarter and by 11% YoY
The company's equity has shrunk by 104% QoQ and by 10% YoY
The debt to equity is up by 50% since the previous quarter and by 11% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.